Dual Chamber Prefilled Syringes Market Size to Reach USD 223.3 Million By 2028: CAGR of 7.0% | Reports And Data

New York, March 18, 2021 (GLOBE NEWSWIRE) — Growing demand for advanced devices to provide controlled drugs is a significant factor influencing growth of the market.The global dual chamber prefilled syringes market is expected to be valued at USD 223.3 million by end of 2028 from a value of USD 130 million in 2020, expanding at a CAGR of 7% over the forecast period. The dual chamber prefilled syringes are increasingly witnessing adoption from research & development activities initiated for introducing improved drugs for the several chronic diseases such as diabetes. According to the data published by World Health Organization (WHO), diabetes is becoming seventh leading cause of death. The mortality from diabetes from 2000 to 2016 has increased to 5% and counted for 1.6 million deaths in 2016. The increasing number of patients suffering from these chronic diseases encouraging investment in research, which in turn is fueling growth of the dual chamber prefilled syringes market. 
However, the threat of counterfeit products posing risk to the patients, which is a key factor hampering growth of the market. The trend of dual chamber prefilled syringes with integrated safety features among end users is estimated to further drive the market growth during the forecast period.Nonetheless, the factors such as investment for research of newer products coupled with increasing approvals from the Food and Drug Administration (FDA) for biopharmaceuticals are estimated to offer several opportunities for growth during the forecast period.Request free sample of this research report at: https://www.reportsanddata.com/sample-enquiry-form/3907Pointers from the reportOtsuka Pharmaceutical Co., Ltd. and H.Lundbeck A/S announced that they have received FDA approval their product – ABILEY MAINTEA, for the monotherapy treatment of bipolar I disorder in adults. Introduction of such products are boosting adoption of dual chamber prefilled syringes, benefiting its market growth.The glass segment hold the largest share in the overall dual chamber prefilled syringes market in 2020 and is projected to hold significant share over the forecast period. The reasonable price of glass syringe boosts its demand and drives further growth of the market.The number of diabetic patients is increasing globally and especially in Asia Pacific owing to large population and changing lifestyle, which is estimated to account in the growth of segment. Owing to such factors, the segment is predicted to witness faster growth over the forecast period.The <1 ml segment is estimated hold significant share in the overall dual chamber prefilled syringes market owing to larger portion of drugs at a time.Asia Pacific is anticipated to expand at a faster CAGR in the dual chamber prefilled syringes market over the forecast period owing to increasing health awareness and increasing healthcare spending in the region. Additionally, the manufacturers are focusing to offer affordable products and are getting commercially approved.Dual Chamber Prefilled Syringes Market by Material (Glass and Plastic), Indication (Hemophilia, Schizophrenia, Endometriosis, Erectile Dysfunction, and Diabetes), Product (Liquid/Powder, Liquid/Liquid), and Region – Global Forecast To 2028; To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/dual-chamber-prefilled-syringes-market
For the purpose of this report, Reports and Data has segmented the global dual chamber prefilled syringes market on the basis of type, product, platform, end user, and region:By MaterialGlassPlasticBy ApplicationLiquid/PowderLiquid/LiquidBy Product<1 ml1 ml-2.5 ml2.5 ml-5.0 ml>5.0 mlBy IndicationHemophiliaSchizophreniaDiabetesErectile DysfunctionEndometriosisOthersOrder Now: https://www.reportsanddata.com/checkout-form/3907By Region Outlook (Revenue, USD Billion; 2018-2028)North AmericaU.S.CanadaEuropeGermanyUKFranceBENELUXRest of EuropeAsia PacificChinaJapanSouth KoreaRest of APACMEASaudi ArabiaUAERest of MEALatin AmericaBrazilRest of LATAMBrowse similar research reports:Immuno-oncology Market Size, Share & Analysis, By Treatment Type (Antibodies, Vaccines, Checkpoint Inhibitors), By Cancer Type (Melanoma, Renal Cell Cancer, Prostate Cancer, Lung Cancer, Blood Cancer, Bladder Cancer), By End-User (Clinics, Hospitals, Cancer Research Institutes), And By Region, Forecast To 2028Cinitapride Market Size, Share & Analysis, By Dosage Type (1 mg, 3 mg), By Distribution Channel (Offline, Online), and By Region, Forecast To 2028Rabies Monoclonal Antibody Market Size, Share & Analysis, By Product Type (Category II Exposure, Category III Exposure), By Application (Adult, Children), And By Region, Forecast To 2028About Reports and DataReports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.Contact Us:John WHead of Business DevelopmentReports And Data | Web: www.reportsanddata.comDirect Line: +1-212-710-1370E-mail: sales@reportsanddata.comRead Full Press Release: https://www.reportsanddata.com/press-release/global-dual-chamber-prefilled-syringes-market